Erasca, Inc. [•] Shares of Common Stock, par value $0.0001 per share Underwriting AgreementErasca, Inc. • July 12th, 2021 • Pharmaceutical preparations • New York
Erasca, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“JPM”), Morgan Stanley & Co. LLC (“MS”) and BofA Securities, Inc. (“BofAS”) are acting as representatives (the “Representatives”), an aggregate of [•] shares of common stock, par value $0.0001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [•] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
INDEMNIFICATION AGREEMENTIndemnification Agreement • July 12th, 2021 • Erasca, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made as of , 20 by and between Erasca, Inc., a Delaware corporation (the “Company”), and , [a member of the Board of Directors/ an officer] of the Company (“Indemnitee”). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee covering indemnification and advancement.
Re: Amended and Restated Employment Letter AgreementLetter Agreement • July 12th, 2021 • Erasca, Inc. • Pharmaceutical preparations • California
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment letter agreement, dated as of February 27, 2020 (the “Prior Agreement”), by and between you and Erasca, Inc. (the “Company”). This Agreement will serve to memorialize the terms of your continued employment with the Company as provided in this Agreement, effective as of July 16, 2021, but subject to the closing of the Company’s initial public offering (“IPO”).
Re: Amended and Restated Employment Letter AgreementLetter Agreement • July 12th, 2021 • Erasca, Inc. • Pharmaceutical preparations • California
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment offer letter, dated as of November 5, 2020 (the “Prior Agreement”), by and between you and Erasca, Inc. (the “Company”). This Agreement will serve to memorialize the terms of your continued employment with the Company as provided in this Agreement, effective as of July 16, 2021, but subject to the closing of the Company’s initial public offering (“IPO”).
Re: Amended and Restated Employment Letter AgreementEmployment Letter Agreement • July 12th, 2021 • Erasca, Inc. • Pharmaceutical preparations • California
This amended and restated employment letter agreement (this “Agreement”) amends and restates that certain employment letter agreement, dated as of February 27, 2020 (the “Prior Agreement”), by and between you and Erasca, Inc. (the “Company”). This Agreement will serve to memorialize the terms of your continued employment with the Company as provided in this Agreement, effective as of July 16, 2021, but subject to the closing of the Company’s initial public offering (“IPO”).
